Open Access Reference Site
Growing advocacy for transparency and access to results of clinical trials has prompted considerable debate on the topic of open access publishing and highlighted a lack of common understanding of what open access is, why it is important, and how it works. Consistent with our goal of promoting greater transparency in industry-sponsored publications, MPIP has developed a reference site to raise awareness of open access, including its importance in meeting shared transparency goals.
Enter your email address below and select "Sign me up" to receive updates on MPIP initiatives.
Many journals accept specialized data that are especially important when it comes to transparency. We've assembled a fairly comprehensive, searchable list that can be used to identify journals that align with your manuscript content for a variety of atypical scenarios.
Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective, published in The BMJ in October 2016, provides guidance on clinically relevant and more informative adverse event reporting, to improve patient care and increase the credibility of industry-sponsored publications.
Transparency Matters is a global educational platform and call to action that raises awareness of the importance of transparency in reporting the results of industry-sponsored research and its impact on credibility. As part of Transparency Matters, MPIP launched What Transparency Means to Me to broaden the conversation around transparency in medical publications, promote best practices, and engage interested parties in this important mission. This platform creates a space for those involved in reporting research results to share their perspectives on why transparency is essential to patient care, scientific understanding, and credibility, and how it can best be achieved when disclosing research results.
Medical Publishing Insights & Practices (MPIP) was founded in 2008 by members of the pharmaceutical industry and the International Society for Medical Publication Professionals (ISMPP) to elevate trust, transparency, and integrity in reporting the results of industry-sponsored research. The major goal of MPIP is to encourage more effective partnership between trial sponsors and medical journals to raise standards in medical publications and expand access to research results.